3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists
US4237160A · kind A · utility
10Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 1979 |
| Grant date | Dec 2, 1980 |
| Priority date | — |
| Expiry date | Nov 27, 1999 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel 3-hydroxymethyldibenzo[b,f]thiepin and derivatives are prepared and employed in the treatment and control of allergic conditions such as allergic asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.